Tag: Non hormonal therapy

Over 70% of women experience hot flashes and night sweats during menopause. So, **does Paxil help with hot flashes?** Yes, a low-dose formulation of paroxetine, the active ingredient in Paxil, is an FDA-approved non-hormonal treatment shown to significantly reduce the frequency and severity of these vasomotor symptoms.

While a significant placebo effect exists for managing hot flashes, studies have shown that clonidine can reduce the frequency, severity, and duration of attacks more effectively than placebo. This medication, originally for blood pressure, is sometimes prescribed to determine whether **does clonidine help with flushing** for certain individuals, but its role has changed over time.

Studies have shown that clonidine can moderately reduce the frequency and severity of hot flashes, particularly in postmenopausal women who cannot take hormonal replacement therapy. However, its effectiveness is often limited by side effects, and it is no longer considered a first-line treatment.

Up to 80% of women experience hot flashes and night sweats during the menopausal transition, prompting a search for effective, non-hormonal relief. In this context, the question of whether **can propranolol stop hot flashes** has been a subject of conflicting clinical studies and ongoing debate within the medical community.

In May 2023, the FDA approved Veozah (fezolinetant) as a non-hormonal treatment for hot flashes associated with menopause. However, in December 2024, the FDA added a Boxed Warning—its most prominent—after rare but serious liver injury cases were reported post-market. Knowing the answer to *Is Veozah safe to take?* involves a careful review of its risks, side effects, and necessary monitoring protocols.

Approximately 75% of people experience hot flashes and night sweats during menopause. For those seeking an alternative, understanding **what drug is similar to Veozah** involves exploring both hormonal and non-hormonal treatment options with different mechanisms of action.

Studies have shown that vaginal vitamin E suppositories can significantly relieve symptoms associated with genitourinary syndrome of menopause (GSM), such as dryness and irritation. So, what are vitamin E suppositories good for? These inserts provide targeted, localized nourishment to soothe and moisturize sensitive vaginal and rectal tissues.

The U.S. Food and Drug Administration (FDA) approved Veozah (fezolinetant) as an oral medication for the treatment of moderate to severe hot flashes, or vasomotor symptoms (VMS), caused by menopause. Given its purpose, many women wonder, 'do you need to take Veozah every day?' to manage these symptoms effectively.

Approved by the FDA in 2023, Veozah (fezolinetant) is a non-hormonal treatment for hot flashes associated with menopause. A common question for many patients is, **is there a generic version of Veozah?** The short answer is no, and the reasons lie in the drug's recent approval and current patent protection.